These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 4369198

  • 1. Specific inhibition of the renin-angiotensin system: A key to understanding blood pressure regulation.
    Brunner HR, Gavras H, Laragh JH.
    Prog Cardiovasc Dis; 1974; 17(2):87-98. PubMed ID: 4369198
    [No Abstract] [Full Text] [Related]

  • 2. Saralasin in human hypertension: the early experience.
    Brunner HR, Laragh JH.
    Kidney Int Suppl; 1979 Mar; (9):S36-43. PubMed ID: 289862
    [No Abstract] [Full Text] [Related]

  • 3. [Renin and sodium and the formation of vascular lesions in hypertension].
    Gavras H, Brunner HR.
    Schweiz Med Wochenschr; 1974 Sep 21; 104(38):1301-10. PubMed ID: 4371116
    [No Abstract] [Full Text] [Related]

  • 4. Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure.
    Davies DL, Beevers DG, Briggs JD, Medina AM, Robertson JI, Schalekamp MA, Brown JJ, Lever AF, Morton JJ, Tree M.
    Lancet; 1973 Mar 31; 1(7805):683-6. PubMed ID: 4120488
    [No Abstract] [Full Text] [Related]

  • 5. The role of the renin-angiotensin system in hypertension.
    Robertson JI.
    Semin Nephrol; 1988 Jun 31; 8(2):120-30. PubMed ID: 3293136
    [No Abstract] [Full Text] [Related]

  • 6. [Renal hypertension].
    Weidmann P, Reubi F.
    Schweiz Med Wochenschr; 1976 Dec 11; 106(50):1778-90. PubMed ID: 796975
    [Abstract] [Full Text] [Related]

  • 7. [Renin-angiotensin system in hypertension].
    Fyhrquist F.
    Duodecim; 1974 Dec 11; 90(9):666-75. PubMed ID: 4371118
    [No Abstract] [Full Text] [Related]

  • 8. [Renin-angiotensin and vasopressin in the pathogenesis of malignant hypertension].
    Möhring J.
    Verh Dtsch Ges Kreislaufforsch; 1977 Dec 11; 43():157-66. PubMed ID: 349924
    [No Abstract] [Full Text] [Related]

  • 9. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB, Morton JJ, Brown JJ, Davies DL, Fraser R, Kelly P, Leckie B, Lever AF, Robertson JI.
    Br Heart J; 1980 Sep 11; 44(3):290-6. PubMed ID: 7000102
    [Abstract] [Full Text] [Related]

  • 10. Renin--angiotensin antagonists and the regulation of blood pressure.
    Samuels AI, Miller ED, Fray JC, Haber E, Barger AC.
    Fed Proc; 1976 Nov 11; 35(13):2512-20. PubMed ID: 185095
    [Abstract] [Full Text] [Related]

  • 11. Sodium retention versus renin-angiotensin system in experimental renal hypertension.
    Liard JF.
    Can J Physiol Pharmacol; 1973 Mar 11; 51(3):238-41. PubMed ID: 4350180
    [No Abstract] [Full Text] [Related]

  • 12. [Significance of renin-angiotensin system inhibitors in the diagnosis of hypertension].
    Stumpe KO, Kolloch RE, Overlack A.
    Med Welt; 1977 Oct 14; 28(41):1645-9. PubMed ID: 927124
    [No Abstract] [Full Text] [Related]

  • 13. Reciprocation of renin dependency with sodium volume dependency in renal hypertension.
    Gavras H, Brunner HR, Thurston H, Laragh JH.
    Science; 1975 Jun 27; 188(4195):1316-7. PubMed ID: 1145199
    [Abstract] [Full Text] [Related]

  • 14. Role of the renin-angiotensin system in renal hypertension. An experimental approach.
    Helmchen U, Kneissler U.
    Curr Top Pathol; 1976 Jun 27; 61():203-38. PubMed ID: 1248262
    [No Abstract] [Full Text] [Related]

  • 15. [What role does the renin-angiotensin system have in the pathogenesis of hypertension?].
    Gross F, Dietz R, Lüth JB, Mann JF.
    Verh Dtsch Ges Kreislaufforsch; 1977 Jun 27; 43():177-87. PubMed ID: 613563
    [No Abstract] [Full Text] [Related]

  • 16. The second Volhard Lecture: The use of blocking agents to define the functions of the renin--angiotensin system.
    Davis JO.
    Clin Sci Mol Med Suppl; 1975 Jun 27; 2():3s-14s. PubMed ID: 802643
    [No Abstract] [Full Text] [Related]

  • 17. [Determination of renin activity and aldosteronuria in 24 hypertensives].
    Sassard J, Bizollon A, Froment A, Vincent M, Lambrinidis S, Gharib C.
    Rev Lyon Med; 1968 Oct 30; 17(16):697-706. PubMed ID: 4305353
    [No Abstract] [Full Text] [Related]

  • 18. Outpatient experience with saralasin.
    Streeten DH, Anderson GH.
    Kidney Int Suppl; 1979 Mar 30; (9):S44-52. PubMed ID: 289863
    [No Abstract] [Full Text] [Related]

  • 19. Intrarenal renin-angiotensin-sodium interdependent mechanism controlling postclamp renal artery pressure and renin release in the conscious dog with chronic one-kidney Goldblatt hypertension.
    Ayers CR, Katholi RE, Vaughan ED, Carey RM, Kimbrough HM, Yancey MR, Morton CL.
    Circ Res; 1977 Mar 30; 40(3):238-42. PubMed ID: 837470
    [Abstract] [Full Text] [Related]

  • 20. The role of the renin--angiotensin system in experimental renal hypertension in dogs.
    Johnson JA, Davis JO, Spielman WS, Freeman RH.
    Proc Soc Exp Biol Med; 1974 Nov 30; 147(2):387-91. PubMed ID: 4373756
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.